Orthocell Ltd (AU:OCC) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Orthocell Limited (ASX: OCC) has requested a trading halt pending a forthcoming announcement regarding the receipt of regulatory approval for its product, Striate, in Canada. The halt will be effective until the company releases the announcement or until the start of normal trading on Friday, 12 July 2024, whichever comes first. This strategic move aims to manage market expectations and maintain orderliness in the trading of Orthocell’s securities.
For further insights into AU:OCC stock, check out TipRanks’ Stock Analysis page.